Alameda, CA.-- (BUSINESS WIRE)--January 11, 2007"Advanced Cell Technology, Inc.'s (OTCBB: ACTC) William M. Caldwell, IV, Chief Executive Officer, was interviewed on CNBC Television's "Power Lunch�” yesterday to comment on a recent discovery by scientists at Wake Forest University describing a method of deriving stem cells from human amniotic fluid and a bill Congress is expected to take up today to widen the scope of funding for embryonic stem cell research.
Mr. Caldwell commented, "The key for any successful company is focus and we are very driven towards taking therapies, specifically for retinal, blood and cardiac disease into the clinic and ultimately patients. We are excited for Wake Forest and Doctor Atala…[t]hose breakthroughs are exciting and we are going to see more breakthroughs. It's important to remember that the key master cell is the embryonic stem cell and that's the one we are focused on.”
Mr. Caldwell continued, "The industry has been starved for many years for lack of capital and we began seeing activity back in 2004 with the voters of California. Now with Congress revisiting the veto that occurred last summer we are going to see a lot more activity in the sector, and we are very excited about it.”
The interview can be "downloaded by clicking here.":http://www.advancedcell.com/media-gallery-item/video-interviews-advanced-cell-technology-ceo-william-caldwell-interviewed-on-cnbc-and-bloomberg-television"
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit "www.advancedcell.com":http://www.advancedcell.com.
Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2006.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Contact
The Investor Relations Group
Investors: "James Carbonara":mailto:jcarbonara@investorrelationsgroup.com, 212-825-3210
Media: "Bill Douglass":mailto:bdouglass@investorrelationsgroup.com, 212-825-3210
Source: Advanced Cell Technology, Inc.
Frequently Requested Info